EditionbyElenaBablenisHaveles
i x ix ix ix
CompleteTestBank
,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation,
f f f f f f f fand Prescription f
Writing
ix
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
ix f f f f f f f f
MULTIPLE CHOICE ix
1. Knowledge of pharmacologyaids the dental professional in ix ix ix ix ix ix ix
a. obtaining a patient’s health history. ix ix ix ix
b. administeringdrugs in the office. ix ix ix ix
c. handling emergencysituations. ix ix
d. selection of a nonprescription medication. ix ix ix ix
e. All of the above. ix ix ix
ANS: i x i x E
All of the choices are true. Because many of our patients are being treated with drugs, knowledge of
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
pharmacologyhelps in understanding and interpreting patients’ responses to health historyquestions.
ix ix ix ix ix ix ix ix ix ix
Knowledge of the therapeutic and adverse effects of medications obviously helps in their proper
ix ix ix ix ix ix ix ix ix ix ix ix ix ix
administration in the office. Emergency situations may be caused by drugs or treated by drugs; thus,
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
knowledge of pharmacology is of great help, especially because a rapid response is sometimes
ix ix ix ix ix ix ix ix ix ix ix ix ix ix
required. A clear understanding of the concepts of drug action, drug handling by the body, and drug
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
interactions will allow the dental practitioner to make proper judgments and grasp the concepts relevant to
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
new drug therapies on the market.
ix ix ix ix ix ix
DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (Medication
ix ix ix ix ix ix ix ix ix ix ix ix
Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hygienist
ix ix ix ix ix ix ix ix ix ix ix ix ix
(Nonprescription Medication) | pp. 2-3
ix OBJ: 1 ix ix ix ix
TOP: NBDHE, 6.0. Pharmacology ix ix
2. Which of the following statements is true regarding planning appointments?
ix ix ix ix ix ix ix ix ix
a. Whetheror not patients are taking medication for systemic diseases is of little ix ix ix ix ix ix ix ix ix ix ix ix
consequence in the dental office.
ix ix ix ix ix
b. Asthmaticpatients should have dental appointments in the morning. ix ix ix ix ix ix ix ix
c. Diabeticpatients usuallyhavefewer problems with amorningappointment ix ix ix ix ix ix ix ix ix
compared with afternoon appointments.
ix ix ix ix
d. Both B and C are true. ix ix ix ix ix
ANS: i x i x D
Asthmatic patients who experience dental anxietyshould schedule their appointments when theyare not rushed
ix ix ix ix ix ix ix ix ix ix ix ix ix ix
or under pressure early in the morning. Diabetic patients usually have relatively fewer problems with a
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
morning appointment. Patients taking medication for systemic diseases mayrequire special handling in
ix ix ix ix ix ix ix ix ix ix ix ix
the dental office.
ix ix ix
DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) |p. 3 ix ix ix ix ix ix ix ix ix
OBJ: 1
ix TOP: NBDHE, 6.0. Pharmacology
ix ix ix
,3. Nutritional or herbal supplements ix ix ix
a. carrythe U.S. Food and Drug Administration (FDA) approval for disease states. ix ix ix ix ix ix ix ix ix ix
b. arenot drugs. ix ix
c. can cause adverse effects. ix ix ix
d. will not interact with other drugs the patient maybe taking.
ix ix ix ix ix ix ix ix ix ix
ANS: i x i x C
Nutritional or herbal supplements are quite capable of causing adverse effects. The majorityof nutritional or
ix ix ix ix ix ix ix ix ix ix ix ix ix ix
herbal supplements do not carry FDA approval for treating disease states. These supplements are drugs
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
and can cause adverse effects and interact with different drugs.
ix ix ix ix ix ix ix ix ix ix
DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) |p. 3 ix ix ix ix ix ix ix ix ix ix ix
OBJ: 1
ix TOP: NBDHE, 6.0. Pharmacologyix ix ix
4. Which type of drugname usuallybegins with a lowercase letter?
ix ix ix ix ix ix ix ix ix ix
a. Brand name ix
b. Codename ix
c. Generic name ix
d. Trade name ix
ANS: i x i x C
Before anydrug is marketed, it is given a generic name that becomes the ―official‖ name of the drug. Each
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
drug is assigned only one generic name selected by the U.S. Adopted Name Council, and the name is
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
not capitalized. The brand name is equivalent to the trade name and is capitalized. Although the brand name
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
is technicallythe name of the companymarketing the product, this term is often used interchangeably
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
with the trade name. The code name is the initial term used within a pharmaceutical company to refer to
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
a drug while it is undergoing investigation and is often a combination of capital letters and numbers,
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
the letters representing an abbreviation of the company name.
ix ix ix ix ix ix ix ix ix
DIF: Comprehension REF: DrugNames |p. 4 ix ix ix ix
OBJ: 3
ix TOP: NBDHE, 6.0. Pharmacology ix ix
5. A drug’s generic name is selected bythe
ix ix ix ix ix ix ix
a. pharmaceutical company manufacturing it. ix ix ix
b. Food and Drug Administration (FDA). ix ix ix ix
c. U.S. Adopted Name Council. ix ix ix
d. Federal Patent Office. ix ix
ANS: i x i x C
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted Name
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
Council. The generic name is not selected by the FDA or the Federal Patent Office. The pharmaceutical
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
company manufacturing the drug clearlyhas an influence on the generic name given its drug, but the
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
final decision is not the company’s.
ix ix ix ix ix ix
DIF: Recall REF: Drug Names | p. 4 ix ix ix ix OBJ:
3 TOP: NBDHE, 6.0. Pharmacology
ix ix ix ix
6. Which of the followingis true concerning generic and trade names of drugs?
ix ix ix ix ix ix ix ix ix ix ix ix
a. A drug mayonlyhave one generic name and one trade name.
ix ix ix ix ix ix ix ix ix ix ix
, b. A drug mayonlyhave one generic name, but it may have several trade names.
ix ix ix ix ix ix ix ix ix ix ix ix ix ix
c. A drug mayhave several generic names, but it mayonlyhave one trade name.
ix ix ix ix ix ix ix ix ix ix ix ix ix ix
d. A drug mayhave several generic names and several trade names.
ix ix ix ix ix ix ix ix ix ix
ANS: i x i x B
Each drug has only one generic name but may have several trade names. For each drug, there is only one
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
generic name. It is not capitalized, and it becomes the ―official‖ name of the drug. The pharmaceutical
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
company discovering the drug gives the drug a trade name. The trade name is protected bythe Federal
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
Patent Law for 20 years from the earliest claimed filing date, plus patent term extensions. Although the
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
brand name is technically the name of the company marketing the product, it is often used
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
interchangeably with the trade name.
ix ix ix ix ix
DIF: Comprehension REF: DrugNames |p. 4 ix ix ix ix
OBJ: 3
ix TOP: NBDHE, 6.0. Pharmacology ix ix
7. Twodrugs that are found to be chemicallyequivalent, but not biologicallyequivalent or
ix ix ix ix ix ix ix ix ix ix ix ix ix
therapeutically equivalent are said to differ in
ix ix ix ix ix ix ix
a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. ix
ANS: i x i x C
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. These
ix ix ix ix ix ix ix ix ix ix ix ix
products are said to differ in their bioavailability. The potencyof a drug is a function of the amount of
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
drug required to produce an effect. The efficacy is the maximum intensity of effect or response that can be
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
produced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of the experimental animals
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
divided by the effective dose for 50% of the experimental animals. If the value of the therapeutic index
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
is small, toxicity is more likely.
ix ix ix ix ix ix
DIF: Recall REF: DrugNames (Drug Substitution) |p. 5 ix ix ix ix ix ix
OBJ: 4
ix TOP: NBDHE, 6.0. Pharmacology ix ix ix
8. Howmany years must pass after a drugpatent expires before other drugcompanies can market the
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
ix same compound as a generic drug?
ix ix ix ix ix
a. 20 years ix
b. 17 years ix
c. 7 years ix
d. 0 years ix
ANS: i x i x D
Once a drug patent expires, competing companies may immediately market the same compound in
ix ix ix ix ix ix ix ix ix ix ix ix ix
generic form. The pharmaceutical company discovering the drug gives the drug a trade name. The trade name
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
is protected bythe Federal Patent Law for 20 years from the earliest claimed filing date, plus the patent term
ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix ix
extensions.
ix
DIF: Application REF: DrugNames (Drug Substitution) |p. 5 ix ix ix ix ix ix
OBJ: 4
ix TOP: NBDHE, 6.0. Pharmacology ix ix ix